Status:
UNKNOWN
Identification and Characterization of Monogenic Diabetes
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Diabetes
Eligibility:
All Genders
Phase:
NA
Brief Summary
Type 1 Diabetes is a multifactorial disease, with a strong genetic contribution of HLA genes, and minor contributions of many additional genes. The investigators hypothesis is that in addition to mult...
Detailed Description
In the first phase of the study the investigators will recruit patients and families, with a strong bias for "extreme" forms of diabetes (very early onset and/or syndromic diabetes) and familial conte...
Eligibility Criteria
Inclusion
- First phase: to have an "extreme" form of diabetes, based on clinical, phenotypic and familial criteria. Parents and siblings of the proband will be sampled.
- Second phase: (after gene identification): to be a relative of the proband, potential carrier of the mutation
Exclusion
- Non consent to participate to the study
Key Trial Info
Start Date :
September 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2015
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT01481623
Start Date
September 1 2012
End Date
September 1 2015
Last Update
June 3 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lariboisiere hospital
Paris, France, 75010